ID
43573
Description
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome for internal use, not to be databased
Keywords
Versions (3)
- 9/12/17 9/12/17 -
- 9/12/17 9/12/17 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
Description
baseline/adverse event checklist
Alias
- UMLS CUI-1
- C0877248
Description
time relative to start of dose
Data type
text
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C3174092
Description
date and time
Data type
datetime
Alias
- UMLS CUI [1]
- C1264639
Description
adverse events
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
initials
Data type
text
Alias
- UMLS CUI [1]
- C2986440
Similar models
visit period 1,2,3 & 4 baseline/adverse event checklist PK and tolerability of ropinirole as 5 new formulations 101468/197
C3174092 (UMLS CUI [1,2])